In the main, this is due to the overwhelming evidence in cancer clinical patient analyzes showing overexpression of SphK1 (Table 1) and the initial findings by Xia and colleagues that provided the evidence of SphK1 being oncogenic [101]. Here, SPHK1 is linked to cancer.